ロード中...
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Most reports on chronic myeloid leukaemia (CML) treatment with tyrosine kinase inhibitors (TKIs) focus on efficacy, particularly on molecular response and outcome. In contrast, adverse events (AEs) are often reported as infrequent, minor, tolerable and manageable, but they are increasingly important...
保存先:
| 出版年: | Leukemia |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991363/ https://ncbi.nlm.nih.gov/pubmed/27121688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.104 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|